Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K211594
    Date Cleared
    2021-11-26

    (186 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Trevo Trak 21 Microcatheter

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Microcatheter is indicated for use in the selective placement of devices and/or fluids, such as contrast media, into the peripheral, coronary, and neuro vasculature during diagnostic and/or therapeutic procedures.

    Device Description

    The Trevo Trak 21 Microcatheter is a single-lumen, braided shaft, variable stiffness catheter with radiopaque marker(s) on the distal end and a Luer hub on the proximal end. The catheter shaft has a hydrophilic coating to reduce friction during use. The radiopaque shaft and distal marker(s) facilitate fluoroscopic visualization.

    AI/ML Overview

    The provided text describes the regulatory filing for the Trevo Trak 21 Microcatheter (K211594), which is a device intended for selective placement of devices and/or fluids in vasculature. This submission focuses on demonstrating substantial equivalence to a previously cleared predicate device (K192122), particularly concerning a change in the recommended minimum inner diameter of the guide catheter.

    Here's an analysis of the acceptance criteria and study information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria specified are primarily related to general device performance and safety rather than a specific algorithmic output, as this is a physical medical device (microcatheter) and not an AI/ML powered device. The "reported device performance" refers to the results of bench testing.

    TestAcceptance Criteria Statement (Implied/Explicit)Reported Device Performance
    Simulated Use/CompatibilityThe user will assess Trevo Trak™ 21 Microcatheter with a worst-case compatible guide catheter in the in vitro simulated use model. (Implicit: Device must function acceptably and compatibly within the simulated use environment, particularly with the new 0.046 inch ID guide catheter).Simulated Use testing met acceptance criteria.
    Particulate CharacterizationUse light obscuration particle counting to measure the total number of particulates generated during simulated use. (Implicit: Particulate generation must be within acceptable limits and comparable to the predicate device to ensure safety).Particulate generation was acceptable and comparable to the predicate device.
    Coating IntegrityUse visual inspection to identify the location, size, and number of occurrences of anomalies on the coated surface of the Trevo Trak™ 21 Microcatheter before and after simulated use. (Implicit: Coating integrity must be maintained before and after simulated use to prevent embolization or other issues).Coating integrity was acceptable both before and after simulated use.
    Track Force TestingUse a Track Tester Model to measure the Trevo Trak™ 21 Microcatheter track force through a guide catheter during simulated use. (Implicit: The device must have an acceptable track force, indicating ease and safety of navigation through the vasculature, especially with the changed guide catheter diameter).Track Testing results met acceptance criteria.
    Shelf-LifeProduct shelf-life testing was performed and results met established criteria. (Implied: Device must maintain its functional and safety characteristics for its labeled shelf-life of six months).Product shelf-life testing met established criteria.
    SterilizationSterility assurance level (SAL) of $10^{-6}$ demonstrated. Meets EO residuals per EN ISO 10993-7 for limited contact delivery system – externally communicating. (Implied: Device must be sterile and have acceptable residual levels of sterilant).SAL of $10^{-6}$ demonstrated. Meets EO residuals per EN ISO 10993-7.
    BiocompatibilityMeets biological safety requirements per EN ISO 10993-1 for an externally communicating medical device with circulating blood contact for less than 24 hours. (Implied: Device materials must be safe for human contact).Meets biological safety requirements per EN ISO 10993-1.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the numerical sample sizes for each bench test conducted on the Trevo Trak 21 Microcatheter (K211594). It mentions that the testing was performed to assess compatibility with a 0.046 inch inner diameter (ID) guide catheter.

    • Test Set Sample Size: Not explicitly stated for K211594's current submission. The wording "User will assess Trevo Trak™ 21 Microcatheter with a worst case compatible guide catheter" suggests a focus on representative scenarios but not a specific 'n' number.
    • Data Provenance: The bench testing appears to be prospective and conducted by Stryker Neurovascular themselves, as part of their submission for K211594. The location of the testing is not specified, but the manufacturer is based in Fremont, California, USA. The shelf-life, sterilization, and biocompatibility data referenced previous testing in K192122, suggesting retrospective use of that data for the current submission.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This section is not applicable as the device is a physical medical instrument, not an AI/ML algorithm requiring expert interpretation of results for ground truth establishment. The "ground truth" for the performance tests relies on established engineering and materials science principles and validated test methods.

    4. Adjudication Method for the Test Set

    This is not applicable for the same reasons as point 3. The assessment of bench test results involves direct measurements, visual inspections, and adherence to predefined engineering specifications, not expert consensus or adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable. The Trevo Trak 21 Microcatheter is a physical medical device, not an AI/ML diagnostic or assistive technology. Therefore, no MRMC study or assessment of human reader improvement with AI assistance was conducted.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This is not applicable as the device is a physical medical device and does not involve any algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" for this device's performance is based on engineering specifications, recognized national/international standards (e.g., ISO 14971 for risk assessment, ISO 10993-1 for biocompatibility), and validated test methods. The successful meeting of these criteria serves as the basis for claiming safety and effectiveness.

    8. The sample size for the training set

    This is not applicable as this is a physical medical device, not an AI/ML system requiring a training set.

    9. How the ground truth for the training set was established

    This is not applicable for the same reasons as point 8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K192122
    Manufacturer
    Date Cleared
    2019-11-22

    (108 days)

    Product Code
    Regulation Number
    870.1200
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Trevo Trak 21 Microcatheter

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Microcatheter is indicated for use in the selective placement of devices and/or fluids, such as contrast media, into the peripheral, coronary, and neuro vasculature during diagnostic and/or therapeutic procedures.

    Device Description

    The Trevo Trak 21 Microcatheter is a single-lumen, braided shaft, variable stiffness catheter with radiopaque marker(s) on the distal end and a luer hub on the proximal end. The catheter shaft has a hydrophilic coating to reduce friction during use. The radiopaque shaft and distal marker(s) facilitate fluoroscopic visualization.

    AI/ML Overview

    The provided text describes bench testing and biocompatibility testing for the Trevo Trak™ 21 Microcatheter. It does not contain information about studies involving AI, human readers, or image analysis, thus many of the requested fields cannot be filled from the given text.

    Here is the information that can be extracted from the provided FDA 510(k) summary regarding the acceptance criteria and the studies performed for the Trevo Trak™ 21 Microcatheter:

    1. A table of acceptance criteria and the reported device performance:

    TestAcceptance CriteriaDevice Performance (Conclusions)
    Dimensional VerificationProcedure and technique of making dimensional measurements using various measurement equipment; Verify dimensions using specified measurement tool.Dimensional verification met acceptance criteria.
    Tensile StrengthBased on EN ISO 10555-1; Identify peak tensile force of catheter joints (catheter to hub junction).Tensile strength met acceptance criteria.
    Air Leak ResistanceMeets freedom from leakage-air aspiration requirement of 4.7.2 of EN ISO 10555-1 and 4.2.2 of EN 1707 (no air bubbles upon aspiration).Air leak resistance of catheter met acceptance criteria.
    Liquid Leak ResistanceMeets freedom from leakage-liquid leak requirement 4.7.1 of EN ISO 10555-1 and 4.2.1 of EN 1707 (no leaks at 300-320 kPa for 30s).Liquid leak resistance of catheter met acceptance criteria.
    Burst PressureResistant to rated burst pressure without leakage or damage per EN ISO 10555-1:2013, Annex F (maintain pressure for at least 2 seconds).Burst pressure met acceptance criteria.
    Particulate CharacterizationAcceptable generation of particulates (measured in four size ranges ≥10μm, ≥25μm, ≥50μm, ≥100μm, and potentially ≥200μm, ≥500μm, ≥1000μm).Particulate generation was acceptable.
    Coating IntegrityVisually characterized before and after simulated use with sufficient magnification to identify defects associated with coating loss.Coating integrity was acceptable.
    Torsion Bond StrengthStrength of catheter shaft when torque is applied; Record maximum observed number of 360-degree rotations.Torsional Bond Strength met acceptance criteria.
    Kink ResistanceMeasure the kink radius of catheter shafts.Kink resistance met acceptance criteria.
    Chemical CompatibilityVisual and dimensional integrity of catheter following exposure to saline and non-ionic contrast liquids.Chemical compatibility met acceptance criteria.
    Tip FlexibilityMeasure the maximum force required to deflect test sample by 45°.Tip Flexibility met acceptance criteria.
    Distal Tip ShapeSmooth, rounded, tapered, or similarly finished to minimize trauma to vessels per EN ISO 10555-1.Distal Tip Shape met acceptance criteria.
    Surface ConditionExternal surface free from extraneous matter, process, or surface defects along the shaft (visual inspection ≥2.5x magnification).Surface condition met acceptance criteria.
    Distal Shaft TrackabilityForce required to track catheter through a tortuous model; lubricity and durability (peak force during advance tracking at 6th cycle).Distal shaft trackability met acceptance criteria.
    Luer Testing per EN 1707Meets requirements 4.1 through 4.7 of EN 1707.Luer testing meets acceptance criteria.
    In-vitro Simulated Use StudyInterventional device delivery, durability, and integrity of the device in a tortuous anatomical model with multiple physician users.All test samples met acceptance criteria.
    Compatibility with Retrieval DevicesAble to resheath a retriever in good condition without a captured thrombus at least 2 times without functional impact and integrity to the tip.Compatibility with Retrieval devices met acceptance criteria.
    Product Integrity Post RemovalNo damage to product following removal from packaging (inspect for kinks, stretches, crushing, RHV damage).Product integrity post removal met acceptance criteria.
    Hemolysis (ISO 10993-4)Direct Contact: Hemolysis ≤ 5%; Extraction: Non-hemolytic (0.0%).Pass
    Thrombosis (ISO 10993-4)Acceptable for clinical application.Pass (with noted potential for complement activation and slight coagulation enhancement).
    Cytotoxicity (ISO 10993-5)No less than or equal to 50% cell viability.Pass
    Sensitization (ISO 10993-10)Not a sensitizer.Pass
    Irritation (ISO 10993-10)No significant irritation.Pass
    Material Mediated Pyrogenicity (ISO 10993-11)No febrile reaction greater than 0.5°.Pass
    Acute Systemic Toxicity (ISO 10993-11)No mortality or evidence of systemic toxicity.Pass
    Physicochemical (ISO 10993-18)Non-volatile Residue ≤ 15 mg; Residue on Ignition ≤ 5 mg; Heavy Metals ≤ 1 ppm; Buffering Capacity ≤ 10.0 mL.Pass
    FTIR (ISO 10993-18)No unexpected readings.Pass
    Latex (ISO 10993-18)No detectable latex.Pass
    Shelf Life TestingMet established criteria (for labeled shelf life of two years for product and packaging).Met established criteria.
    SterilizationSterility Assurance Level (SAL) of 10^-6; EO residuals per EN ISO 10993-7 for limited contact delivery system - externally communicating.Demonstrated to meet SAL of 10^-6, met EO residuals.

    2. Sample size used for the test set and the data provenance:

    • The document mentions "All test samples met acceptance criteria" for the In-vitro Simulated Use Study, but the specific sample size for each bench test is not provided in this summary.
    • Data Provenance: The studies are described as "design verification and design validation testing conducted on the Trevo Trak 21 Microcatheter," "bench testing," and "biocompatibility testing." The methods refer to international standards (EN ISO, ASTM), suggesting the tests were conducted according to established laboratory protocols. No information is provided about data provenance in terms of country of origin or if it's retrospective/prospective, as these are bench and biocompatibility tests, not clinical studies.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • For the bench testing and biocompatibility testing, "experts" in the sense of clinical reviewers establishing ground truth for diagnostic accuracy are not applicable. The 'In-vitro Simulated Use Study' mentions evaluation by "multiple physician users" for device delivery, durability, and integrity, but the specific number and qualifications are not detailed.

    4. Adjudication method for the test set:

    • Not applicable for bench testing and biocompatibility. The tests have predefined pass/fail criteria based on physical measurements, chemical analyses, or visual inspections against a standard.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • No MRMC comparative effectiveness study was done. This is a medical device (microcatheter), not an AI-powered diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • Not applicable. This is a physical medical device, not an algorithm.

    7. The type of ground truth used:

    • For the performance data (bench testing), the "ground truth" is defined by pre-established specifications and international standards (e.g., ISO, EN). The device's performance is measured against these quantitative and qualitative criteria.
    • For biocompatibility, the "ground truth" is established by biocompatibility testing results against predefined thresholds for biological response according to ISO 10993 standards.

    8. The sample size for the training set:

    • Not applicable. This is a physical medical device, not a machine learning model requiring a training set.

    9. How the ground truth for the training set was established:

    • Not applicable. No training set was used.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1